This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Effective management of high blood pressure could prevent more than 518,000 annual deaths from cardiovascular disease around the world, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026. The meeting is in Arlington, Virginia, Oct. 7–11, 2026, and focuses on recent advances in basic and clinical research on high blood pressure and its relationship to cardiac and kidney disease, stroke, obesity and genetics.
Untreated high blood pressure can cause blood vessel damage, including narrowing of the arteries and aneurysms, and lead to many heart conditions, including coronary artery disease, heart failure, enlarged left heart and metabolic syndrome. High blood pressure is the most prevalent and modifiable risk factor for cardiovascular disease and can affect adults in all age groups. Based on the American Heart Association's 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, the treatment goal for adults with hypertension is less than 130/80 mm Hg.
Noncommunicable diseases (NCDs) are responsible for roughly three out of five deaths globally, and approximately 73% of these deaths occur in low- or middle-income countries. Cardiovascular disease accounts for more of these deaths than other chronic health conditions such as diabetes, cancers and chronic respiratory illnesses.
"In this study, we analyzed existing data to assess if expanding use of NCD preventive health care services across 20 countries worldwide could reduce cardiovascular deaths.
Source link







